Arpetol (Umifenovir) 100 mg 20 film-coated tablets

Arpetol (Umifenovir) 100 mg film-coated tablets, 20 tablets — Lekpharm, Belarus

Arpetol is an antiviral medicine produced by the Belarusian company SOOO “Lekpharm” (Logoysk, Minsk region). Each film-coated tablet contains 100 mg of umifenovir hydrochloride (as the monohydrate). The pack contains 20 tablets. It is a direct-acting systemic antiviral that is also described as an immunomodulatory agent, used for the prevention and treatment of influenza and other acute respiratory viral infections, in the complex therapy of recurrent herpes, and to prevent postoperative infectious complications. In Belarus the medicine is dispensed without a prescription; in the countries where it is registered, use it according to the patient leaflet or the doctor’s prescription.

Product overview

• Trade name: Arpetol (Арпетол)
• Active ingredient: umifenovir hydrochloride 100 mg per tablet (as umifenovir hydrochloride monohydrate)
• Dosage form: round biconvex film-coated tablets, white or almost white, for oral use
• Pack size: 20 tablets (2 blisters of 10) in a carton box with the patient leaflet
• Manufacturer and marketing authorisation holder: SOOO “Lekpharm”, Logoysk, Minsk region, Belarus
• Country of origin: Belarus
• Product category: antiviral medicine — systemic direct-acting antiviral, also described as an immunomodulatory agent
• Age: adults and children over 3 years (the 100 mg strength — from 6 years)
• Dispensing: without prescription in Belarus

What umifenovir is used for

In adults and children over 3 years of age:

• prevention and treatment of influenza A and B and other acute respiratory viral infections (ARVI)
• complex therapy of recurrent herpes infection
• prevention of postoperative infectious complications

In children from 3 to 18 years additionally: complex therapy of acute intestinal infections of rotavirus origin — the 50 mg strength from 3 years, the 100 mg strength from 6 years.

How to use

The medicine is taken orally, before meals. Treatment should start as soon as the first symptoms of influenza or another ARVI appear, preferably no later than 3 days from the onset. If the symptoms, including a high temperature (38 °C or more), persist after three days of treatment, consult a doctor.

Adults — single dose 200 mg (two 100 mg tablets):

• Treatment of influenza and other ARVI: 200 mg 4 times a day (every 6 hours) for 5 days
• Non-specific prophylaxis during an epidemic: 200 mg twice a week for 3 weeks
• Prophylaxis after direct contact with a person ill with influenza or ARVI: 200 mg once a day for 10–14 days
• Complex therapy of recurrent herpes: 200 mg 4 times a day for 5–7 days, then 200 mg twice a week for 4 weeks
• Prevention of postoperative infectious complications: 200 mg two days before surgery, then on days 2 and 5 after surgery

Children — single dose 50 mg at 3–6 years, 100 mg at 6–12 years, 200 mg over 12 years; the same regimens as for adults.

The recommended schedule and duration of intake must be followed. Do not take a double dose to make up for a missed one — take the missed dose as soon as possible and continue the course.

Possible side effects

Adverse reactions are rare (may occur in no more than 1 person in 1000): sudden shortness of breath, difficulty breathing, swelling of the face or lips, skin rash, itching — symptoms of an allergic reaction. These may appear immediately after the first dose or later. Stop taking the medicine and consult a doctor immediately if they occur.

Important precautions

• Do not use in case of allergy to umifenovir or any other component of the tablet
• Do not use in the first trimester of pregnancy or during breastfeeding; in the second and third trimesters use only after consulting a doctor
• Do not give to children under 3 years of age (any strength) or under 6 years of age (100 mg strength)
• The tablet contains lactose monohydrate — patients with intolerance to certain sugars should consult a doctor before use
• The medicine does not affect attention or reaction speed
• Umifenovir is registered in Belarus and a number of CIS countries; it is not an approved medicine in the European Union or the United States

Storage

Store at a temperature not exceeding 25 °C, out of the reach and sight of children. Do not use after the expiry date printed on the blister and carton.

Important notice

The photo shows the original manufacturer’s packaging; the graphic design of the pack delivered may differ depending on the country of registration. This information is for reference only and does not replace the patient leaflet or medical advice. Consult a doctor or pharmacist before use.

📦 Ask about availability and delivery to your country on WhatsApp